Johnson & Johnson: The safety data is encouraging, and the findings suggest that as this combination enters phase 3, it is expected to achieve outpatient administration.

Zhitongcaijing · 6d ago
Johnson & Johnson: The safety data is encouraging, and the findings suggest that as this combination enters phase 3, it is expected to achieve outpatient administration.